Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 7/2017

01-07-2017 | Original Contributions

Does Post-operative Psychotherapy Contribute to Improved Comorbidities in Bariatric Patients with Borderline Personality Disorder Traits and Bulimia Tendencies? A Prospective Study

Authors: Francesca Gallé, Pietro Maida, Assunta Cirella, Elena Giuliano, Patrizia Belfiore, Giorgio Liguori

Published in: Obesity Surgery | Issue 7/2017

Login to get access

Abstract

Background

Borderline personality disorder (BPD) and eating disorders may affect the outcomes of bariatric surgery. This study was aimed to evaluate the influence of a post-operative dialectical behavioral therapy (DBT) intervention on weight loss and comorbidities in a sample of comorbid obese Italian patients with BPD traits and bulimia tendencies who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB).

Methods

One hundred fifty-four LRYGB or LAGB patients showing BPD and bulimia traits and type II diabetes, hypertension, and/or sleep apnea (OSAS) voluntarily adhered to DBT (n = 72) or treatment as usual (n = 82) for 12 months after surgery. Total weight loss (%TWL) and remission/improvement of comorbidities were considered as outcomes. Differences between treatment groups and between LRYGB and LAGB subgroups were evaluated through Student’s t test for TWL and chi-square test for comorbidities.

Results

DBT was more effective than treatment as usual (TAU) in reducing weight loss (p < .001). Reduction of comorbidities was higher in patients treated with DBT, as for diabetes (p = .68), hypertension (p = .02), and OSAS (p = .03). LRYGB outcomes seem to be significantly better than those of LAGB, mainly in TAU group.

Conclusion

Our findings confirm the effectiveness of DBT in enhancing post-bariatric weight loss and reduction of comorbidities in patients showing BPD traits and bulimia tendencies. Further in-depth investigations and a longer follow-up are needed to strengthen these results.
Literature
1.
Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847–50.CrossRefPubMed
2.
3.
4.
McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139:933–49.CrossRefPubMed
5.
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34.CrossRefPubMed
6.
Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8.
7.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.CrossRefPubMed
8.
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23.CrossRefPubMedPubMedCentral
9.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMed
10.
Crémieux PY, Ledoux S, Clerici C, et al. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010;20(7):861–70.CrossRefPubMed
11.
Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts. 2008;1(1):52–9.CrossRefPubMed
12.
Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche (SICOB). Linee guida e stato dell’arte della chirurgia bariatrica e metabolica in Italia. Napoli: EDISES; 2008.
13.
Medical Advisory Secretariat. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9(22).
14.
Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149:275–87.CrossRefPubMedPubMedCentral
15.
16.
Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–93.CrossRefPubMed
17.
Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164(2):328–34.CrossRefPubMed
18.
19.
Peterhänsel C, Wagner B, Dietrich A, et al. Obesity and co-morbid psychiatric disorders as contraindications for bariatric surgery? A case study. Int J Surg Case Rep. 2014;5:1268–70.CrossRefPubMedPubMedCentral
20.
Livhits M, Mercado C, Yermilov I, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22:70–89.CrossRefPubMed
21.
Marcus MD, Kalarchian MA, Courcoulas AP. Psychiatric evaluation and follow-up of bariatric surgery patients. Am J Psychiatry. 2009;166(3):285–91.CrossRefPubMed
22.
Kinzl JF. Morbid obesity: significance of psychological treatment after bariatric surgery. Eat Weight Disord. 2010;15:275–80.
23.
Beck NN, Johannsen M, Støving RK, et al. Do postoperative psychotherapeutic interventions and support groups influence weight loss following bariatric surgery? A systematic review and meta-analysis of randomized and nonrandomized trials. Obes Surg. 2012;22(11):1790–7.CrossRefPubMed
24.
Rizvi SL, Linehan MM. Dialectical behavior therapy for personality disorders. Curr Psychiatry Rep. 2001;3(1):64–9.CrossRefPubMed
25.
Verheul R, Van Den Bosch LM, Koeter MW, et al. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry. 2003;182:135–40.CrossRefPubMed
26.
Himes SM, Grothe KB, Clark MM, et al. Stop regain: a pilot psychological intervention for bariatric patients experiencing weight regain. Obes Surg. 2015;25(5):922–7.CrossRefPubMed
27.
Safer DL, Telch CF, Agras WS. Dialectical behavior therapy adapted for bulimia: a case report. Int J Eat Disord. 2001;30(1):101–6.CrossRefPubMed
28.
29.
World Health Organization. A global brief on hypertension. WHO press, Geneva 2013—the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281–357.CrossRef
30.
Iber C, Ancoli-Israel S, Cheeson A, et al. The AASM manual for the scoring of sleep and associated events, rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
31.
Linehan MM, Comtois KA, Murray MA, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs. therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63:757–66.CrossRefPubMed
32.
Wisniewski L, Kelly E. The application of dialectical behavior therapy to the treatment of eating disorders. Cogn Behav Pract. 2003;10(2):131–8.CrossRef
33.
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed
34.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.CrossRefPubMed
35.
Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931–40.CrossRefPubMedPubMedCentral
36.
Pontiroli AE, Zakaria AS, Mantegazza E, et al. Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol. 2016;15(1):39.CrossRefPubMedPubMedCentral
37.
Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.
38.
Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315(2):150–63.CrossRefPubMed
39.
Mitchell JE, King WC, Courcoulas A, et al. Eating behavior and eating disorders in adults before bariatric surgery. Int J Eat Disord. 2015;48(2):215–22.CrossRefPubMed
40.
White MA, Kalarchian MA, Levine MD, et al. Prognostic significance of depressive symptoms on weight loss and psychosocial outcomes following gastric bypass surgery: a prospective 24-month follow-up study. Obes Surg. 2015;25(10):1909–16.CrossRefPubMedPubMedCentral
41.
Kalarchian MA, King WC, Devlin MJ, et al. Psychiatric disorders and weight change in a prospective study of bariatric surgery patients: a 3-year follow-up. Psychosom Med. 2016;78(3):373–81.CrossRefPubMedPubMedCentral
42.
Cassin SE, Sockalingam S, Wnuk S, et al. Cognitive behavioral therapy for bariatric surgery patients: preliminary evidence for feasibility, acceptability, and effectiveness. Cogn Behav Pract. 2013;20(4):529–43.CrossRef
43.
Fabricatore AN. Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference? JADA. 2007;107(1):92–9.CrossRef
44.
Capoccia D, Monaco V, Coccia F, et al. Axis II disorders, body image and childhood abuse in bariatric surgery candidates. Clin Ter. 2015;166(4):E248–53.PubMed
45.
Sansone RA, Sansone LA. Borderline personality disorder in the medical setting: suggestive behaviors, syndromes, and diagnoses. Innov Clin Neurosci. 2015;12:39–44.PubMedPubMedCentral
Metadata
Title
Does Post-operative Psychotherapy Contribute to Improved Comorbidities in Bariatric Patients with Borderline Personality Disorder Traits and Bulimia Tendencies? A Prospective Study
Authors
Francesca Gallé
Pietro Maida
Assunta Cirella
Elena Giuliano
Patrizia Belfiore
Giorgio Liguori
Publication date
01-07-2017
Publisher
Springer US
Published in
Obesity Surgery / Issue 7/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2581-1

Other articles of this Issue 7/2017

Obesity Surgery 7/2017 Go to the issue

Original Contributions

Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction

Original Contributions

Moderating the Enthusiasm of Sleeve Gastrectomy: Up to Fifty Percent of Reflux Symptoms After Ten Years in a Consecutive Series of One Hundred Laparoscopic Sleeve Gastrectomies

Letter to the Editor

Another Fatal Outcome with a Biliopancreatic Limb Length of 200 cm with One Anastomosis Gastric Bypass

Letter to the Editor

Rare Cause of Small Bowel Ischemia During Pregnancy After Roux-en-Y Gastric Bypass

Biography

Natan Zundel Majerowick, M.D.

Original Contributions

Are Obese Patients at an Increased Risk of Pelvic Floor Dysfunction Compared to Non-obese Patients?